In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Shares of Philip Morris ( NYSE: PM) snapped six straight sessions of gains, as the stock closed 0.74% down at $122.89 on ...
FDA officials say that Zyn contains fewer harmful ingredients than cigarettes and other types of chewing tobacco, which are ...
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...
The US Food and Drug Administration has today authorised Swedish Match’s ZYN nicotine pouches, marking a milestone for the Philip Morris International subsidiary.
Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA ...
Zyn is a pouch containing nicotine powder that is intended to rest in a user's mouth while the stimulant is absorbed into their bloodstream. The FDA's authorization of Zyn marks the first time ...
The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs.
This marketing decision from the FDA covers 2 nicotine strengths, 3 mg and 6 mg, and 10 flavors of the small tobacco-free ...
These items have become popular in c-stores as traditional tobacco sales plunge, and their approval sets the stage for ...
Zyn products will be allowed to stay on the market after federal health officials said Thursday that the popular nicotine ...